Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Revenue increased due to efficient progress in the Public Sector segment on responses to various legal and regulatory amendments, operational support following the introduction of systems compliant with standard specifications, and the introduction of new systems for individual customers, as well as the provision of leasing business packages and various systems and equipment sales in the Industrial Sector segment. Profit in the Industrial Sector segment declined due to higher research and development expenses and other factors.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥4,405 million (YoY +4.0%) |
| Operating profit | ¥421 million (YoY +411.9%) |
| Ordinary income | ¥428 million (YoY +396.6%) |
| Profit attributable to owners of the parent | ¥289 million (YoY +454.0%) |
| Net income per share | ¥52.18 |
| Equity ratio | End of the current fiscal period 73.5 % / End of previous period 63.3 % |
| Total assets | ¥21,460 million |
| Net assets | ¥15,772 million |
| Full-year earnings forecast | Net Sales ¥23,500 million (YoY -16.0%) / Operating profit ¥2,465 million (YoY -60.9%) / Ordinary income ¥2,477 million (YoY -60.6%) / Profit attributable to owners of the parent ¥1,700 million (YoY -62.0%) |
| Annual Dividend Forecast | ¥140 → ¥100 |
| Segment revenue | Public sector ¥3,405.03 million, Industrial Sector ¥1,000.76 million |
| Segment profit | Public sector ¥382.57 million, Industrial Sector ¥40.79 million |
| Depreciation and amortization | ¥188,484 thousand |
| Impairment loss | None applicable (material impairment loss related to non-current assets) |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No (no material changes to the scope of consolidation during the period) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | None (対象者：Not applicable) |
| Issued Shares at Period-End | 5,837,200 |
| Treasury Shares at Period-End | 286,535 |
| Factors Behind Changes in Business Performance | Revenue increased due to efficient progress in the Public Sector segment on responses to various legal and regulatory amendments, operational support following the introduction of systems compliant with standard specifications, and the introduction of new systems for individual customers, as well as the provision of leasing business packages and various systems and equipment sales in the Industrial Sector segment. Profit in the Industrial Sector segment declined due to higher research and development expenses and other factors. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Public Sector segment, the Company efficiently advanced responses to various legal and regulatory amendments, operational support following the introduction of systems compliant with standard specifications, and the introduction of new systems for individual customers. In the Industrial Sector segment, revenue increased due to the provision of leasing business packages and production control systems, systems for medical institutions, and equipment sales, among other factors. Profit declined, however, due to higher research and development expenses, including costs related to the development of next-generation products for pharmaceutical inventory management systems.